How magnetic fields and 3D printers will create the pills of tomorrow

June 09, 2020

Doctors could soon be administering an entire course of treatment for life-threatening conditions with a 3D printed capsule controlled by magnetic fields thanks to advances made by University of Sussex researchers.

Engineers and pharmaceutical scientists from the University of Sussex and The University of Texas at Austin have developed a triggerable and remotely controllable system for on-demand drug delivery.

Using 3D printing technology and magnetic actuation, researchers have been able to prove the concept of a drug release triggered by magnetic fields capable of inhibiting the proliferation of cancer cells in vitro.

While the research is in its initial phases, the researchers are working towards a system where it is possible to drive the drug delivery system towards the required position in the body using external means such as permanent magnets. The technology would allow for a drug to be applied close to the lesion.

The researchers foresee that the targeted delivery offered by the new system could help eliminate harmful side effects caused by treatments like chemotherapy which damage neighbouring healthy cells. The device also offers a level of control that would guard against inappropriate dosing which has become the main cause of adverse effects from drug therapy.

Kejing Shi, doctoral researcher in the University of Sussex's School of Life Sciences and lead author of the study, said: "The device offers the potential for personalised treatment through the loading of a given drug in a particular concentration and releasing it within different dosage patterns. All results confirmed that the device can provide a safe, long-term, triggerable and reutilizable way for localized disease treatments such as cancer."

Professor Ali Nokhodchi, head of Pharmaceutics Research Lab at the University of Sussex School of Life Sciences and corresponding author of the article, said: "The device delivers enhanced efficacy and safety through optimal drug distribution and absorption in the targeted location at the (sub)cellular level. This device has the potential to be used in treatments for cancer, diabetes, pain, and myocardial infarction which require variable release kinetics where patients' suffer from discomfort or inconvenience if they currently rely on untunable monotonic drug treatment."

In the study, to be published in the August edition of Colloids and Surfaces B: Biointerfaces, a device containing anticancer drug 5-fluorouracil and composed of a magnetic polydimethylsiloxane (PDMS) sponge cylinder and a 3D printed reservoir showed an inhibition effect on Trex cell growth.

Repeated, localised drug release was achieved by switching the applied magnetic field on and off. Varying the intensity of the magnetic field when applied to the device causes the internal magnetic sponge to be compressed at different ratios, which releases different amounts of the drug.

In vitro cell culture studies demonstrated the stronger the magnetic field applied, the higher the drug release and the greater inhibition effects on Trex cell growth.

The researchers say that this kind of smart treatment could be available for patients in hospitals within a decade.

Dr Elizabeth-Rendon Morales, Senior Lecturer in Engineering at the University of Sussex's School of Engineering and Informatics, said: "Fine tuning and characterizing the device performance allows the system being capable of releasing the drug within different dosage patterns thus, having the potential to offer personalized treatment."

Dr Rodrigo Aviles-Espinosa, a Lecturer in Biomedical Engineering at the University of Sussex's School of Engineering and Informatics, says "Advancing this process further, we could create different compartments in the capsule with different sponges or employ other techniques where the macroporous sponge properties can be tailored to hold two or more substances without being mixed which could deliver more complex courses of treatment."
-end-


University of Sussex

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.